CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Frontage Holdings Corp is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Frontage Holdings Corp
700 Pennsylvania Dr
Phone: (610) 232-0100p:610 232-0100 Exton, PA  19341-1129  United States Ticker: 15211521

Business Summary
Frontage Holdings Corporation is a holding company. The principal activities of the Company and its subsidiaries are to provide laboratory and related services to pharmaceutical and agrochemical companies. The Company is a contract research organization (CRO) providing integrated, science-driven, product development services throughout the drug discovery and development process to enable life science companies to achieve their drug development goals. Its segments include North America and the People’s Republic of China (PRC). The North America segment includes laboratory testing, chemistry, manufacturing and control (CMC), preclinical research, early stage clinical/bioequivalence and chemistry services in the USA and Canada. PRC segments include laboratory testing, CMC, preclinical research, early stage clinical/ bioequivalence and chemistry services in the PRC. Its preclinical research services consist of drug metabolism and pharmacokinetic (DMPK) and safety and toxicology.
(Source: ARS)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
6/30/202312/31/2022Yes----

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Executive Chairman of the Board LiSong 64 1/3/2023 2/10/2021
Chief Executive Officer Abdul E.Mutlib 62 1/3/2023 6/1/2017
Chief Financial Officer GaoJun 48 2/1/2024 2/1/2024
12 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Acme Biosciences, Inc. 3941 E Bayshore Rd Palo Alto California United States
Experimur LLC 4045 South Morgan Street Chicago IL United States
Concord Biosciences, LLC 10845 Wellness Way Concord OH United States
Nucro-Technics, Inc. 2000 Ellesmere Rd Scarborough ON Canada
Frontage Laboratories Inc 700 Pennsylvania Dr EXTON PA United States

Business Names
Business Name
1521
Acme Biosciences, Inc.
Concord Biosciences, LLC
7 additional Business Names available in full report.

General Information
Number of Employees: 1,613 (As of 6/30/2023)
Outstanding Shares: 2,098,754,910 (As of 2/27/2024)
Stock Exchange: HKG
Fax Number: (610) 232-0101


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Thursday, March 28, 2024